For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221010:nRSJ4036Ca&default-theme=true
RNS Number : 4036C GENinCode PLC 10 October 2022
TR-1: Standard form for notification of major holdings
1. Issuer Details
ISIN
GB00BL97B504
Issuer Name
GENINCODE PLC
UK or Non-UK Issuer
UK
2. Reason for Notification
Other
Comments
Thames Ventures VCT 1 plc and Thames Ventures VCT 2 plc (formerly Downing ONE
VCT plc and Downing FOUR VCT plc) appointed Foresight Group LLP as follows;
Thames Ventures VCT 1 plc as Investment Advisor;Thames Ventures VCT 2 plc as
Discretionary Manager
3. Details of person subject to the notification obligation
Name
Downing LLP
City of registered office (if applicable)
London
Country of registered office (if applicable)
Greater London
4. Details of the shareholder
Name City of registered office Country of registered office
Thames Ventures VCT 2 plc London UK
5. Date on which the threshold was crossed or reached
04-Jul-2022
6. Date on which Issuer notified
10-Oct-2022
7. Total positions of person(s) subject to the notification obligation
% of voting rights attached to shares (total of 8.A) % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) Total of both in % (8.A + 8.B) Total number of voting rights held in issuer
Resulting situation on the date on which threshold was crossed or reached 6.650000 0.000000 6.650000 6367318
Position of previous notification (if applicable) 11.080000 0.000000 11.080000
8. Notified details of the resulting situation on the date on which the
threshold was crossed or reached
8A. Voting rights attached to shares
Class/Type of shares ISIN code(if possible) Number of direct voting rights (DTR5.1) Number of indirect voting rights (DTR5.2.1) % of direct voting rights (DTR5.1) % of indirect voting rights (DTR5.2.1)
GB00BL97B504 6367318 0 6.650000 0.000000
Sub Total 8.A 6367318 6.650000%
8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))
Type of financial instrument Expiration date Exercise/conversion period Number of voting rights that may be acquired if the instrument is % of voting rights
exercised/converted
Sub Total 8.B1
8B2. Financial Instruments with similar economic effect according to
(DTR5.3.1R.(1) (b))
Type of financial instrument Expiration date Exercise/conversion period Physical or cash settlement Number of voting rights % of voting rights
Sub Total 8.B2
9. Information in relation to the person subject to the notification
obligation
2. Full chain of controlled undertakings through which the voting rights
and/or the financial instruments are effectively held starting with the
ultimate controlling natural person or legal entities (please add additional
rows as necessary)
Ultimate controlling person Name of controlled undertaking % of voting rights if it equals or is higher than the notifiable threshold % of voting rights through financial instruments if it equals or is higher Total of both if it equals or is higher than the notifiable threshold
than the notifiable threshold
Downing LLP Thames Ventures VCT 2 plc 6.650000 6.650000%
10. In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
11. Additional Information
Downing LLP continues to manage the Healthcare share class of Thames Ventures
VCT 2 plc which is the residual holding disclosed above.
12. Date of Completion
10.10.22
13. Place Of Completion
London
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END HOLFLFFDIFLILIF